Patient age >= 18 years
Zubrod performance status of 0-3
T1-3 N0 M0 adenocarcinoma of the prostate
Prostate volume = 100 cc
Signed study-specific consent form
Extension of local tumor to involve adjacent organs other than seminal vesicles (T4)
Prostate volume > 100 cc
Nodal involvement
Metastatic disease
Prior pelvic radiotherapy except as part of combination therapy for prostate cancer
History of scleroderma
Patients with psychiatric or addictive disorder that would preclude obtaining informed consent

NCT01352598_inc_T1
Person
Patient age
NCT01352598_inc_T2
Value
>= 18 years
NCT01352598_inc_T3
Measurement
Zubrod performance status
NCT01352598_inc_T4
Value
0-3
NCT01352598_inc_T5
Measurement
T
NCT01352598_inc_T6
Value
1-3
NCT01352598_inc_T7
Measurement
N
NCT01352598_inc_T8
Measurement
M
NCT01352598_inc_T9
Value
0
NCT01352598_inc_T10
Value
0
NCT01352598_inc_T11
Scope
T1-3 N0 M0
NCT01352598_inc_T12
Condition
adenocarcinoma
NCT01352598_inc_T13
Qualifier
prostate
NCT01352598_inc_T14
Measurement
Prostate volume
NCT01352598_inc_T15
Value
= 100 cc
NCT01352598_inc_T17
Condition
Extension of local tumor
NCT01352598_inc_T18
Qualifier
adjacent organs
NCT01352598_inc_T19
Negation
other than
NCT01352598_inc_T20
Qualifier
seminal vesicles
NCT01352598_inc_T21
Scope
adjacent organs other than seminal vesicles
NCT01352598_inc_T22
Measurement
Prostate volume
NCT01352598_inc_T23
Value
> 100 cc
NCT01352598_inc_T24
Condition
Nodal involvement
NCT01352598_inc_T25
Condition
Metastatic disease
NCT01352598_inc_T26
Temporal
Prior
NCT01352598_inc_T27
Qualifier
pelvic
NCT01352598_inc_T28
Procedure
radiotherapy
NCT01352598_inc_T29
Negation
except
NCT01352598_inc_T30
Procedure
combination therapy
NCT01352598_inc_T31
Condition
prostate cancer
NCT01352598_inc_T32
Condition
prostate cancer
NCT01352598_inc_T33
Observation
History
NCT01352598_inc_T34
Condition
scleroderma
NCT01352598_inc_T35
Condition
 or addict at would
NCT01352598_inc_T36
Condition
addictive disorder